Latest Breaking News On - Demyelinating polyneuropathy immunovant - Page 1 : comparemela.com

NIU Phase 2 Topline Results and Corporate Updates April 2024 Forward-Looking Statements Forward-Looking Statements .

United statesRoivant priovantDemyelinating polyneuropathy immunovantDermatomyositis priovantGravis immunovantExchange commissionCapital allocationPositive resultsShare repurchase program including purchaseEntire sumitomo stakeReducing share countNext chapterRobust late stageEye diseaseInflammatory demyelinating polyneuropathyInfectious uveitis